P A Robertson1, H J Ross, R A Figlin. Show Affiliations » 1. University of California, Los Angeles.
Abstract
Entities: Disease Gene
Mesh: See more » Drug EvaluationFibrosarcoma/drug therapyFibrosarcoma/etiologyFibrosarcoma/pathologyHead and Neck Neoplasms/drug therapyHemorrhage/chemically inducedHemorrhage/pathologyHumansHypotension/chemically inducedMaleMiddle AgedNecrosisNeoplasms, Radiation-Induced/drug therapyNeoplasms, Radiation-Induced/pathologyRecombinant Proteins/adverse effectsRecombinant Proteins/therapeutic useTumor Necrosis Factor-alpha/adverse effectsTumor Necrosis Factor-alpha/therapeutic use
Substances: See more » Recombinant ProteinsTumor Necrosis Factor-alpha
Year: 1989 PMID: 2802424 DOI: 10.7326/0003-4819-111-8-682
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391